Tablets of 7- (3'- (methylhydroxylethylamino) -2'-hydroxypropyl) -theophylline nicotinate with prolonged action. II. Retardation of the drug release by polymer coating of tablets
Chodkowska-Granicka, B.; Pawlak, Z.; Pawlak, E.; Surowiecki, J.
Acta Poloniae Pharmaceutica 29(6): 618-622
1972
ISSN/ISBN: 0001-6837 PMID: 4670139 Document Number: 45025
Document emailed within 1 workday
Related Documents
Pawlak, E.; Chodkowska-Granicka, B.; Surowiecki, J. 1971: Tablets of 7-(3'-(methylhydroxyethylamino)-2'-hydroxypropyl)-theophylline nicotinate with delayed action. I. Moderation of the release of the active substance by some additives Acta Poloniae Pharmaceutica 28(1): 43-47Tomassini, L.; Michailova, D.; Naplatanova, D.; Slavtschev, P. 1979: The effects of various factors on the in vitro velocity of drug release from repository tablets. Part 4: Isoniazid (Rimicid) respository tablets Die Pharmazie 34(12): 812-814
Kincl, M.; Bibic, R.; Veber, M.; Vrecer, F. 2003: Development and optimization of the drug release determination of iron from iron prolonged release tablets Die Pharmazie 58(4): 257-259
Qadan, A.; Süss, W. 2000: Controlled release of carbamazepine from pellets and tablets manufactured with hydroxypropyl methylcellulose Die Pharmazie 55(8): 628
Kaiko, R.F.; Fitzmartin, R.D.; Thomas, G.B.; Goldenheim, P.D. 1992: The bioavailability of morphine in controlled-release 30-mg tablets per rectum compared with immediate-release 30-mg rectal suppositories and controlled-release 30-mg oral tablets PharmacoTherapy 12(2): 107-113
Shah, S.U.; Shah, K.U.; Rehman, A.; Khan, G.M. 2011: Investigating the in vitro drug release kinetics from controlled release diclofenac potassium-ethocel matrix tablets and the influence of co-excipients on drug release patterns Pakistan Journal of Pharmaceutical Sciences 24(2): 183-192
Mellstrand, T.; Svedmyr, N.; Fagerström, P.O. 1980: Absorption of theophylline from conventional and sustained-release tablets European Journal of Respiratory Diseases. Supplement 109: 54-60
Stozek, T.; Krówczyński, L.; Bohdanowicz, T. 1983: Comparative studies on drug release from tablets in vitro and its biological availability. II. Biological availability of sodium salicylate from tablets of various formulations Acta Poloniae Pharmaceutica 40(1): 77-87
Kasperek, R.; Polski, A.; Sobótka-Polska, K.; Poleszak, E. 2014: Influence of polymer type on the physical properties and the release study of papaverine hydrochloride from tablets Polimery W Medycynie 44(1): 5-12
Jonkman, J.H.; van der Boon, W.J.; Schoenmaker, R.; Holtkamp, A.; Thürkow-Luikens, A.J. 1984: The absolute bioavailability of a new pediatric sustained release theophylline tablet, when given as whole or divided tablets International Journal of Clinical Pharmacology Therapy and Toxicology 22(9): 506-510
Rabiant, J.; Soulairac, A.; Dorme, N. 1972: Urinary excretion of heptaminol after ingestion of conventional tablets and delayed-action tablets Annales Pharmaceutiques Francaises 30(9): 601-609
Mehsud, S.U.; Khan, G.M.; Hussain, A.; Akram, M.; Akhlaq, M.; Khan, K.A.; Shakoor, A. 2016: Controlled release matrix tablets of glipizide: Influence of different grades of ethocel and Co-excipient on drug release Pakistan Journal of Pharmaceutical Sciences 29(3): 779-787
McKenzie, S.; Baillie, E. 1979: Serum theophylline levels in asthmatic children after oral administration of a slow-release aminophylline preparation (Phyllocontin Continus tablets) Journal of International Medical Research 7(Suppl 1): 22-27
Witchitz, S.; Moisson, P.; Kolsky, H. 1984: A comparative trial of ordinary metoprolol tablets and metoprolol sustained-release tablets in hypertensive patients at rest and on exercise Pharmatherapeutica 3(8): 566-572
Hollenbach, K.; Pintye-Hódi, K.; Kedvessy, G. 1980: On the Polymorphism of barbiturates in powders and tablets. Part 4: the dissolution of barbital B and barbital a (modifications i and IIi and their release from tablets Die Pharmazie 35(1): 32-35
Innes, J.A.; Campbell, I.W.; Millar, J.; Munro, J.F. 1975: A comparison of the efficacy and acceptability of fenfluramine tablets (BP) and prolonged action capsules Postgraduate Medical Journal 51(Suppl 1): 160-162
Jürgensen Eide, G. 1973: Influence of complex formation on drug release from tablets Acta Pharmaceutica Suecica 10(3): 229-246
Shoaib, M.H.; Tazeen, J.; Merchant, H.A.; Yousuf, R.I. 2006: Evaluation of drug release kinetics from ibuprofen matrix tablets using HPMC Pakistan Journal of Pharmaceutical Sciences 19(2): 119-124
Khalil, S.A.; Ali, L.M.; Abdel Khalek, M.M. 1974: Effects of ageing and relative humidity on drug release. 2. Tolbutamide tablets Die Pharmazie 29(1): 38-40
von Schrader, H.W.; Buscher, G.; Dierdorf, D.; Freytag, A.; Mügge, H.; Wolf, D. 1985: Bioavailability and tolerance of xanthinol nicotinate depot preparations. Comparison of a conventional 500 mg xanthinol nicotinate depot tablet with new 500 mg and 1 g depot tablets Arzneimittel-Forschung 35(9): 1468-1472